Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ovarian cancer testing study: no drugs, just data

NCT ID NCT07539844

Not yet recruiting Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Apr 26, 2026 · Last updated May 24, 2026 · Updated 5 times

Summary

This study looks at how consistently different labs measure a protein called FRa in ovarian cancer tissue samples. It uses archived biopsies from about 1,000 women with ovarian cancer. No new treatments or drugs are given—researchers simply compare test results from local and central labs. The goal is to improve future testing and treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.